Koji Haratani
Koji Haratani publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.
- World rank
- #236,507 of 7,710,434 ranked researchers
- Rank in Japan
- #1,840 of 383,136
- Works
- 213
- Citations
- 4.2k
- Citations per work
- 19.8
What does Koji Haratani research?
Koji Haratani's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13362.6%
- Medicine13362.6%
- Life Sciences4019.0%
- Everything else3918.4%
- 1Oncology38% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Molecular Biology8% of their works
- 4Immunology8% of their works
- 5Radiology, Nuclear Medicine and Imaging4% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Koji Haratani's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Immune Checkpoint Blockade, PD-1 and PD-L1, ALK Inhibitors, Chemotherapy, EGFR Mutations and Genomic Profiles.
- CT Screening
- Immunity
- Cetuximab
- Cancer Genomics
- Breast Cancer
- Genomic Profiles
- Chemotherapy
- PD-1 and PD-L1
- Clinical Trials
- Targeted Therapy
- Immune Checkpoint Blockade
- ALK Inhibitors
- EGFR Mutations
- Small-Cell Lung Cancer
- HER2
- Mutational Signatures
- Dendritic Cells
- KRAS Mutations
- Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Targeted Therapy603 topics
- Clinical Trials512 topics
- Immune Checkpoint Blockade461 topic
- PD-1 and PD-L1461 topic
- ALK Inhibitors371 topic
- Chemotherapy374 topics
- EGFR Mutations371 topic
- Genomic Profiles141 topic
- Small-Cell Lung Cancer141 topic
- Breast Cancer101 topic
- HER2101 topic
- Cancer Genomics91 topic
- Mutational Signatures91 topic
- Cetuximab71 topic
- Dendritic Cells71 topic
- Immunity71 topic
- KRAS Mutations71 topic
- CT Screening61 topic
- Lung Cancer61 topic
Where does Koji Haratani work?
Koji Haratani's main affiliation in the publication record is Kindai University, Japan.
How many publications and citations does Koji Haratani have?
OpenAlex counts 213 works and 4,223 citations for Koji Haratani, an h-index of 28, ranking #236,507 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Koji Haratani. Posts are plain text and can be reported.